Android app Apple app link

Revolution Medicines, Inc. (RVMD) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$97.63
Day's range
$99.9

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
06/09/2026 UBS Michael Yee $175.00 $148.45   17.89%
06/02/2026 RBC Capital Leonid Timashev $182.00 $163.68   11.19%
05/21/2026 Bernstein Jeffrey Walch $151.00 $153.73   -1.78%
04/14/2026 H.C. Wainwright Robert Burns $169.00 $136.30   23.99%
02/26/2026 Wells Fargo Eva Fortea Verdejo $144.00 $103.24   39.48%
01/27/2026 Oppenheimer Jay Olson $150.00 $97.78   53.41%
01/21/2026 RBC Capital Leonid Timashev $140.00 $116.22   20.46%
01/13/2026 Goldman Sachs Andrea Newkirk $73.00 $119.95   -39.14%
11/03/2025 RBC Capital Leonid Timashev $77.00 $58.84   30.86%
10/17/2025 National Bank Alex Stranahan $80.00 $53.81   48.67%
08/19/2025 Piper Sandler Kelsey Goodwin $75.00 $36.56   105.14%
05/14/2025 H.C. Wainwright Robert Burns $72.00 $41.88   71.92%
04/01/2025 Stifel Nicolaus Benjamin Burnett $64.00 $33.62   90.36%
01/08/2025 UBS Eliana Merle $71.00 $44.33   60.16%
11/07/2024 Piper Sandler Joseph Catanzaro $70.00 $56.09   24.8%
11/04/2024 H.C. Wainwright Raghuram Selvaraju $62.00 $55.87   10.97%
10/28/2024 Guggenheim Michael Schmidt $82.00 $46.96   74.62%
10/28/2024 Oppenheimer Jay Olson $60.00 $46.83   28.12%
10/15/2024 Oppenheimer Jay Olson $55.00 $49.22   11.74%
09/17/2024 Piper Sandler Joseph Catanzaro $57.00 $44.24   28.84%
08/08/2024 Needham Ami Fadia $61.00 $42.73   42.76%
07/15/2024 Wedbush Robert Driscoll $59.00 $47.01   25.52%
04/19/2024 Stifel Nicolaus Ben Burnett $43.00 $35.83   20.01%
04/12/2024 Needham Ami Fadia $46.00 $37.41   22.96%
04/12/2024 Oppenheimer Jay Olson $45.00 $37.41   20.29%
04/09/2024 Raymond James Laura Prendergast $48.00 $32.99   45.5%
11/16/2023 Raymond James Dane Leone $30.00 $21.25   41.18%

Revolution Medicines Inc FAQ's

Revolution Medicines Inc has been rated by research analysts at UBS, RBC Capital, H.C. Wainwright, Oppenheimer, Bernstein, Truist Financial in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.